CSIMarket
 
Bruker Corporation  (BRKR)
Other Ticker:  
 
 
Price: $92.1000 $0.27 0.294%
Day's High: $93.29 Week Perf: 0.59 %
Day's Low: $ 91.00 30 Day Perf: 15.05 %
Volume (M): 1,354 52 Wk High: $ 94.23
Volume (M$): $ 124,657 52 Wk Avg: $71.31
Open: $91.21 52 Wk Low: $53.79



 Market Capitalization (Millions $) 13,566
 Shares Outstanding (Millions) 147
 Employees 6,900
 Revenues (TTM) (Millions $) 2,818
 Net Income (TTM) (Millions $) 322
 Cash Flow (TTM) (Millions $) -262
 Capital Exp. (TTM) (Millions $) 110

Bruker Corporation
Bruker Corporation is a leading company in scientific instrumentation and solutions.
It provides high-performance scientific instruments and analytical solutions for various industries, including life science research, pharmaceuticals, biotechnology, food, and environmental testing.
The company was founded in 1960, and its headquarters are in Billerica, Massachusetts, USA.
Bruker Corporation has a wide range of products and services, including mass spectrometry, magnetic resonance imaging (MRI), microscopy and imaging, and X-ray analysis.
It also provides software and services that support the use of its instruments and analytical solutions.
Bruker Corporation is a global company with a strong presence in North Americas, Europe, Asia-Pacific, Middle East, and Africa.
The company has subsidiaries in more than 70 countries and employs around 8,200 people worldwide.
One of the strengths of Bruker Corporation is its focus on innovation and R&D.
The company invests heavily in R&D, and it has over 2,500 patents and patent applications.
Bruker Corporation has a track record of introducing groundbreaking products that have helped advance research and development in various industries.
In summary, Bruker Corporation is a leading company in scientific instrumentation and solutions with a wide range of products and services.
It operates globally and focuses on innovation and R&D.
Its products and services are used in various industries, including life science research, pharmaceuticals, biotechnology, food, and environmental testing.


   Company Address: 40 Manning Road Billerica 1821 MA
   Company Phone Number: 663-3660   Stock Exchange / Ticker: NASDAQ BRKR
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CERT   -2.94%    
MASS        0.9% 
• View Complete Report
   



Bruker Corporation

Bruker Corporation Witnesses Impressive Revenue Growth during the July to September 30, 2023 Fiscal Period

Bruker Corporation: Impressive Revenue Growth and Modest Profit Increase Signal Promising Future
In the July to September 30, 2023 fiscal period, Bruker Corporation showcased its resilience and potential by achieving a double-digit revenue rise of 16.262% to an impressive $742.80 million. This exceptional growth was led by a dedicated focus on improving sales, a strategy that paid off handsomely. Moreover, the company also witnessed a modest profit increase of 1.69% to $0.60 per share, further reinforcing its strong financial performance.
Compared to the same period the previous year, the growth figures are even more impressive. Earnings per share (EPS) soared by an astonishing 53.85% from $0.39 to $0.60, while revenue advanced by a substantial 8.995% from $681.50 million. Net earnings for the July to September 30, 2023 fiscal period came in at $88.700 million, a 0.34% increase from the $88.400 million reported during the same period a year ago.

Bruker Corporation

Bruker Corporation Defies Industry Decline with 18.18% Increase in Double Digit Earnings per Share Amidst April to June 30, 2023 Financial Period



The Laboratory Analytical Instruments industry has taken an unexpected turn with the impressive fiscal performance of Bruker Corporation. While many of its sector contemporaries experienced declines in business, BRKRsn managed to defy the trend and achieve significant revenue and income growth. In this article, we delve into the recent financial results released by the company and highlight some interesting facts.
Revenue Growth and Income Improvement:
In the fiscal span closing on June 30, 2023, Bruker Corporation showcased remarkable revenue growth. Compared to the previous year, their revenue increased by an impressive 15.823%, reaching a total of $681.50 million. This growth stands in stark contrast to the overall decline witnessed in the Laboratory Analytical Instruments sector.

Bruker Corporation

Bruker Corporation's Remarkable ROI and Profits Surge in Q1 2023

Bruker Corporation Achieves Impressive ROI and Reports Improved Profit Margins in Q1 2023
Bruker Corporation,
a leader in scientific research equipment and solutions, has reported strong financial results for the first quarter of 2023. The company achieved a return on average invested assets (ROI) of 13.41%, surpassing its average ROI of 12.49%. Despite a decline in net income, the company has shown improvement in ROI compared to the previous quarter.
Within the healthcare sector, 49 other companies had a higher return on investment than Bruker Corporation. However, the company's overall ROI ranking has improved significantly in the first quarter of 2023, reaching 454 from the total ROI ranking of 827 in the fourth quarter of 2022.






 

Bruker's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com